1. Apatinib inhibits macrophage-mediated epithelial–mesenchymal transition in lung cancer
    Shuliang Liu et al, 2018, RSC Adv. CrossRef
  2. Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size
    Xueyu Zhao et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
  3. In Vitro and In Vivo Inhibitory Effect of Gujin Xiaoliu Tang in Non-Small Cell Lung Cancer
    Chao Hou et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
  4. The role of tumour microenvironment: a new vision for cholangiocarcinoma
    Ziyan Chen et al, 2018, J Cell Mol Med CrossRef
  5. Autocrine VEGF signalling on M2 macrophages regulates PD-L1 expression for immunomodulation of T cells
    Yin-Siew Lai et al, 2018, J Cell Mol Med CrossRef
  6. Conventional Western Treatment Combined With Chinese Herbal Medicine Alleviates the Progressive Risk of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
    Tsai-Hui Lin et al, 2019, Front. Pharmacol. CrossRef
  7. Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer
    Jia-Xin Li et al, 2019, Integr Cancer Ther CrossRef
  8. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip
    Li Gao et al, 2020, BMC Med Genomics CrossRef
  9. Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer
    Zhu Lingling et al, 2020, Pathology - Research and Practice CrossRef
  10. Astragalus membranaceus–Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors
    Fu-Ling Chang et al, 2020, BioMed Research International CrossRef
  11. null
    Alice Grigore, 2020 CrossRef
  12. Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses
    Han Huang et al, 2020, Front. Pharmacol. CrossRef
  13. Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1
    Shan‑Tong Jiang et al, 2018, Int J Mol Med CrossRef
  14. A survey of herbal medicines as tumor microenvironment‐modulating agents
    Chan‐Ran Park et al, 2020, Phytotherapy Research CrossRef
  15. Bleomycin inhibits proliferation and induces apoptosis in TPC‑1 cells through reversing M2‑macrophages polarization
    Hongwei Liu et al, 2018, Oncol Lett CrossRef
  16. A meta‑analysis and bioinformatics exploration of the diagnostic value and molecular mechanism of miR‑193a‑5p in lung cancer
    Zu‑Cheng Xie et al, 2018, Oncol Lett CrossRef
  17. Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: A review
    Yuqi Fan et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  18. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy
    Zhe Ge et al, 2020, Front. Oncol. CrossRef
  19. Anticancer Properties of Lobetyolin, an Essential Component of Radix Codonopsis (Dangshen)
    Christian Bailly, 2020, Nat. Prod. Bioprospect. CrossRef
  20. Tumor-regulated macrophage type 2 differentiation promotes immunosuppression in laryngeal squamous cell carcinoma
    Peng Zhang et al, 2020, Life Sciences CrossRef
  21. Anticancer activities of TCM and their active components against tumor metastasis.
    Kailong Wang et al, 2021, Biomed Pharmacother CrossRef
  22. Traditional Chinese medicine and lung cancer——From theory to practice
    Zhang Li et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  23. Impact of TCM on Tumor-Infiltrating Myeloid Precursors in the Tumor Microenvironment
    Jinlong Liu et al, 2021, Front. Cell Dev. Biol. CrossRef
  24. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways
    Xin-Xin Deng et al, 2021, Journal of Ethnopharmacology CrossRef
  25. The application of traditional Chinese medicine against the tumor immune escape
    Jing Xu et al, 2020 CrossRef
  26. Immunological Effects of Histotripsy for Cancer Therapy
    Alissa Hendricks-Wenger et al, 2021, Front. Oncol. CrossRef
  27. Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer
    Myong Hak Ri et al, 2021, Journal of Ethnopharmacology CrossRef
  28. The State of Immunotherapy in Hepatobiliary Cancers
    Farhan Z. Ilyas et al, 2021, Cells CrossRef
  29. Therapeutic Potential of Natural Products in Lung Cancer
    Qi-Xing Yan et al, 2021, International J. of Pharmacology CrossRef
  30. Identifying PIF1 as a Potential Target of Wenxia Changfu Formula in Promoting Lung Cancer Cell Apoptosis: Bioinformatics Analysis and Biological Evidence
    Xiangjun Yin et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  31. Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment
    Fengqian Chen et al, 2021, Front. Oncol. CrossRef
  32. Immunohistochemical Detection of Pro-Inflammatory and Anti-Inflammatory Interleukins in the Lungs of Sheep with Jaagsiekte
    Emin KARAKURT et al, 2022 CrossRef
  33. null
    Md Robiul Karim et al, 2022 CrossRef
  34. Molecular basis of melatonin protective effects in metastasis: A novel target of melatonin
    Fatemeh Sadoughi et al, 2022, Biochimie CrossRef
  35. Study on the Action Mechanism of the Yifei Jianpi Tongfu Formula in Treatment of Colorectal Cancer Lung Metastasis Based on Network Analysis, Molecular Docking, and Experimental Validation
    Wanli Zhu et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  36. Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness
    Kristine Cate S. Pe et al, 2022, PLoS ONE CrossRef
  37. Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models
    Hongkui Chen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  38. Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects
    Jiatong Zhang et al, 2022, Front. Immunol. CrossRef
  39. Traditional Herbal Medicine: A Potential Therapeutic Approach for Adjuvant Treatment of Non-small Cell Lung Cancer in the Future
    Jie Huang et al, 2022, Integr Cancer Ther CrossRef